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SyncytializationHERV (Human Endogenous Retrovirus)-encoded envelope proteins are implicated in the development of
the placenta. Indeed, Syncytin-1 and -2 play a crucial role in the fusion of human trophoblasts, a key step in pla-
centation. Other studies have identiﬁed two otherHERV env proteins, namely EnvP(b) and EnvV, both expressed
in the placenta. In this study, we have fully characterized both env transcripts and their expression pattern and
have assessed their implication in trophoblast fusion. Through RACE analyses, standard spliced transcripts were
detected, while EnvV transcripts demonstrated alternative splicing at its 3′ end. Promoter activity and expression
of both genes were induced in forskolin-stimulated BeWo cells and in primary trophoblasts. Although we have
conﬁrmed the fusogenic activity of EnvP(b), overexpression or silencing experiments revealed no impact of
this protein on trophoblast fusion. Our results demonstrate that both env genes are expressed in human tropho-
blasts but are not required for syncytialization.
© 2011 Elsevier Inc. All rights reserved.Introduction
Most Human Endogenous Retroviruses (HERVs) have invaded our
genome at least 25 million years ago upon infection of germ cell lines.
They represent retroviral ancestral sequences and their loci are gener-
ally non-functional due to the accumulation of deleterious mutations
or deletion events having occurred during evolution. Furthermore,
the majority of HERV sequences are solitary LTRs, having resulted
from recombination between the two LTRs present in former proviral
DNA (Boeke and Stoye, 1997; Lander et al., 2001).
Intact HERV-derived open reading frames have been identiﬁed and
characterized (de Parseval et al., 2003; Villesen et al., 2004). A few of
them, and in particular, former envelope (env) genes, have been sug-
gested to be implicated in various biological processes. In fact, two
HERV env proteins termed Syncytin-1 and Syncytin-2, which have
retained their fusogenic capacity (Blaise et al., 2003; Blond et al.,
2000; Mi et al., 2000), have been clearly implicated in a crucial step
occurring during placenta formation, more precisely in the process
of fusion of villous cytotrophoblasts (a phenomenon also known as
syncytialization) (Blaise et al., 2003; Blond et al., 2000; Mi et al.,tréal, Département des sciences
, Canada H2X 3X8. Fax: +1 514
as),
ie@uqam.ca (J. Lafond),
rights reserved.2000; Vargas et al., 2009). These fusion events lead to the formation
of the syncytiotrophoblast layer, which is renewed by continuous
fusion of underlying cytotrophoblast and plays a fundamental role in
allowing the adequate exchange of nutrients and hormones as well
as other components between the mother and the foetus (Castellucci
et al., 2000; Kingdom et al., 2000; Midgley et al., 1963).
The implication of Syncytin-1 and Syncytin-2 in the formation of the
syncytiotrophoblast is further supported by that fact that their expres-
sion is high in the placenta and can be induced in the BeWo choriocar-
cinoma cell line following the addition of fusion-stimulating agents
(Blaise et al., 2003; Kudo and Boyd, 2002; Prudhomme et al., 2004;
Vargas et al., 2008, 2009). Receptors of both Syncytin-1 and Syncytin-
2, namely ASCT2 and MFSD2, respectively, have also been identiﬁed
and strongly suggested to be involved in the fusion process (Blond
et al., 2000; Esnault et al., 2008; Lavillette et al., 2002). In recent reports,
an association between decreased expression levels of Syncytin-1 and
Syncytin-2 and a decrease in trophoblast fusion has been demonstrated
in samples from pre-eclampsia (PE) patients (Chen et al., 2006, 2008;
Keith et al., 2002; Knerr et al., 2002; Kudaka et al., 2008; Langbein
et al., 2008; Lee et al., 2001; Vargas et al., 2011).
Recently, two HERV env genes named EnvP(b) and EnvV have been
identiﬁed (Aagaard et al., 2005; Kjeldbjerg et al., 2008; Villesen et al.,
2004). The EnvP(b) gene is ubiquitously expressed and encodes a 664
amino acid protein,which has retained its fusogenic capacitywhen tested
in cell lines such as HeLa and COS cells, while EnvV is expressed in amore
placenta-speciﬁc manner, but its encoded protein has not been shown to
have maintained a fusogenic potential (Blaise et al., 2005). Amore recent
2 A. Vargas et al. / Virology 425 (2012) 1–10study has demonstrated that two almost identical EnvV genes, termed
EnvV1 and EnvV2, are separated by approximately 30 kbp on chromo-
some 19q13.41. The 536 amino acid envV2-encoded protein has been
strongly preserved during primate evolution (Kjeldbjerg et al., 2008).
Due to the conserved nature of both EnvP(b) and EnvV2 genes,
alike previous studies, we speculated that both env proteins could in-
tervene in placenta development. Both of these proteins have been
evaluated for their fusogenic potential in various cell lines although
no trophoblastic cell models were included in this assay (Blaise
et al., 2005). It was thus important to make a clearer assessment of
their potential implication in trophoblast fusion. In this work, we
have characterized both EnvP(b) and EnvV transcripts, have detailed
their expression pattern and have tested for their potential role
in trophoblast fusion. Overall, our results demonstrate that these en-
velope proteins are not required in trophoblast syncytialization.
Results
Through RNA interference experiments, we have previously
reported that both Syncytin-1 and Syncytin-2 were involved in theA 
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Fig. 1. Characterization of EnvP(b) and EnvV transcripts in human trophoblasts. Total RNA ex
EnvP(b) (A) and EnvV (B) mRNA. Sequencing of ampliﬁed products conﬁrmed the spliced
script. A single poly A addition site is depicted for EnvP(b) transcripts, while multiple poly A
3′ ends. On the left side of each panel, outer and inner PCR ampliﬁcation products from 5′ R
ladder). Position of the primer-binding site (PBS), transcription start sites (broken arrow),
sites (underlined), polyadenylation signals (pA) (underlined), and poly A cleavage sites (arr
in addition to both 5′ and 3′ LTR regions bordering the HERV proviral DNA. It should be stre
the 5′ LTR of the EnvP(b)-expressing proviral DNA, which is not present in this ﬁgure (Blais
initiation site and subsequent numbers relate to the cDNA. The length of introns is also indprocess of trophoblast fusion (Vargas et al., 2009). A former report
has presented data indicating that EnvP(b) had maintained its fuso-
genic potential, unlike EnvV (Blaise et al., 2005). However, this study
has not conducted similar assays in trophoblast cell models. Conse-
quently, we speculated that both EnvP(b) and EnvV proteins might
potentially be implicated in trophoblast fusion. The EnvV2 gene was
selected in this study as it showed conservation during the evolution
in all simian species, unlike EnvV1 (Kjeldbjerg et al., 2008).
Characterization of the human EnvP(b) and EnvV transcripts
To explore and compare the functional relevance of EnvP(b) and
EnvV2 (for clarity, EnvV2 will now be referred to EnvV for the rest
of the manuscript) versus Syncytin-1 and Syncytin-2 in trophoblast
fusion, their transcripts were ﬁrst characterized. These analyses
were performed in order to determine if different splicing patterns
and transcription initiation sites could be detected, potentially
leading to alternative HERV env isoforms. For these experiments,
we used primary cytotrophoblasts, which differentiate and fuse spon-
taneously after 48 h of culture (Vargas et al., 2008). After 72 h, RNAtracted from isolated primary cytotrophoblasts was used for 5′ and 3′ RACE analyses of
nature of the transcript and revealed a single transcription initiation site for each tran-
signals were noted for EnvV transcripts, which originated from two alternatively spliced
ACE and 3′ RACE analyses are presented after migration on an agarose gel (M=100 bp
putative TATA and CAAT boxes (in a box), splice donor (SD) and splice acceptor (SA)
ow) are all indicated. Gag/pol-like sequences as well as the envelope ORFs are depicted
ssed that an additional MER51 retroelement sequence has also been identiﬁed next to
e et al., 2005). Nucleotide positioning is based on the +1 position of the transcription
icated.
3A. Vargas et al. / Virology 425 (2012) 1–10from these cells was isolated and served to identify 5′ and 3′ ends of
both transcripts by 5′ and 3′ RACE (rapid ampliﬁcation of cDNA ends)
analyses. To perform these analyses, primers were designed either
from the upstream region next to the EnvP(b) and EnvV coding seg-
ment (for 5′ RACE) or in the 3′ region (for 3′ RACE) based on the pre-
viously described proviral DNA structure (see Blaise et al., 2005;
Kjeldbjerg et al., 2008). As depicted in Figs. 1A and B, both RACE ex-
periments generated a number of ampliﬁed products. However, all
sequenced 5′ RACE signals, which were speciﬁc to the HERV env tran-
scripts, mapped to a single transcription initiation site, which was
near an upstream putative TATA-like box for both transcripts in addi-
tion to a CAAT box for EnvP(b). The TATA box sequences were
based on previously reported TATA variants listed in the Gene Pro-
moter Miner software (http://gpminer.mbc.nctu.edu.tw/help.php).
Sequencing of these PCR products further revealed the expected
singly spliced form of the two transcripts. Splice donor and splice ac-
ceptor consensus sequences were also present in the HERV DNA
sequence at the border of the splice junction in the 5′ LTR and up-
stream of the env ORF region, respectively. For EnvP(b), 3′ RACE ana-
lyses also led to the identiﬁcation of a single polyadenylation addition
site adjacent to a poly A signal AAUAAA in the 3′ LTR, which is typical
of retroviral env gene transcripts. However, for EnvV, two different 3′
ends were sequenced, one of which presented characteristics similar
to the EnvP(b) transcripts (Fig. 1B). However, another more abundant
transcript presented an additional spliced event in the 3′ untranslated
regions joining a third exon at a 920 bp distance. Moreover, in this
multiply spliced transcript, two cleavage sites were sequenced and
were present at nearby multiple and superimposed poly A signals.A
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Fig. 2. Expression pattern of EnvP(b) and EnvV in human trophoblasts. Total RNA was extrac
from primary trophoblasts cultured up to 4 days (D–E). EnvP(b) and EnvV expression was ei
PCR (B-E). For panels D and E, normalized relative expression levels represent the mean
trophoblasts isolated from four different normal placentas.However, none of these alternative spliced transcripts was predicted
to produce EnvV proteins with variation in their amino acid
sequences.
These results hence demonstrated that the EnvP(b) transcript was
expressed as a typical singly spliced transcript and that the transcrip-
tion initiation was likely dependent on a CAAT box. For EnvV, results
demonstrated alternative splicing of the transcript, which led to a
typical form and a multiply spliced transcript with resulting multiple
poly A addition sites.
Expression of EnvP(b) and EnvV in BeWo cells and primary trophoblasts
No studies have yet tested the expression pattern of EnvP(b) and
EnvV genes in primary trophoblasts or in the BeWo cell line model.
Since Syncytin-1 and Syncytin-2 gene expression has been shown to
be induced in the choriocarcinoma BeWo cell line upon induction of
fusion, we ﬁrst wanted to determine if EnvV and EnvP(b) expression
also correlated with fusion. To characterize the expression of
each HERV env gene, we thus analyzed their expression in BeWo
cells treated or not with Forskolin, a very potent fusion-inducing
agent. Similarly treated non-fusogenic JEG-3 and Jar trophoblastic
cell lines (Al-Nasiry et al., 2006; Vargas et al., 2008) were also ana-
lyzed in parallel. RT-PCR analyses conducted on BeWo cells showed
an increase of both EnvP(b) and EnvV expression in stimulated condi-
tions whereas their expression remained either unchanged (EnvP(b))
or absent (EnvV) in JEG-3 and Jar cells (Fig. 2A). Additionally, real-
time PCR analysis revealed high induction of mRNA levels for both
genes upon 48 h of stimulation of BeWo cells (Figs. 2B and C).C
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values+/−S.E.M. of quantiﬁed mRNA levels from three experiments performed with
4 A. Vargas et al. / Virology 425 (2012) 1–10We next measured mRNA levels in freshly isolated primary cyto-
trophoblasts. In culture conditions, primary human cytotrophoblasts
undergo spontaneous differentiation, as judged by secretion of hor-
mones such as hCG and hPL (Daoud et al., 2005, 2006) and extensive
cell fusion, which peaks at day 4 (Vargas et al., 2009). By RT-PCR, we
thus examined the expression level of EnvP(b) and EnvV at different
time points (Figs. 2D and E). As negative controls, PCR ampliﬁcation
was carried out in the absence of the RT step and, after gel migration,
results showed no speciﬁc bands (data not shown). As demonstrated
in Fig. 2D, a signiﬁcant increase in EnvP(b) mRNA levels was noted,
which importantly dropped at 96 h. In contrast, the level of EnvV
mRNA peaked at 48 h after onset of culture and then drastically de-
clined (Fig. 2E).
These results demonstrated that both EnvP(b) and EnvV are
strongly stimulated following stimulation of BeWo cells and upon
culturing of primary trophoblasts, although in these latter cells,
induced expression was transient for both analyzed transcripts.
Promoter activities of EnvP(b) and EnvV in stimulated BeWo cells
To further analyze the transcriptional activation of both env genes
in BeWo cells, promoter constructs consisting of the 5′ LTR region
positioned upstream from the luciferase reporter gene were generat-
ed and transfected in BeWo cells prior to stimulation (Fig. 3). Upon
transfection of these constructs with the lacZ-encoding vector (for
normalization), BeWo cells were induced for cell fusion and com-
pared to unstimulated transfected cells in terms of normalized
luciferase activity (Figs. 3A and B). Our results ﬁrst demonstrated
that basal luciferase activity in unstimulated BeWo cells was very
low for both promoters (data not shown), which was compatible
with our RT-PCR and real-time PCR results (Figs. 2A–C). Upon forsko-
lin stimulation, a reproducible increase (2.5 fold) in luciferase activity
driven by the two promoters was noted.
Our data thereby conﬁrmed the RT-PCR experiments and
suggested that the increase in mRNA levels of EnvP(b) and EnvV in
stimulated BeWo cells was occurring at the transcriptional level.A 
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Fig. 3. Activation of EnvP(b) and EnvV promoters by forskolin. Luciferase reporter construc
and EnvV genes (vs. the empty vector pGL3 basic) was co-transfected with pRcActin-LacZ
triplicates. Resulting luciferase activity was normalized against β-galactosidase activity.
pGL3basic-transfected BeWo cells used as a negative control (* pb0.05).Overexpression of EnvP(b) or EnvV in BeWo cells does not induce fusion
Previous studies have demonstrated that EnvP(b) had retained its
fusogenic potential. However, none of the tested cell lines in this
report had included trophoblasts or cell line model such as BeWo
cells (Blaise et al., 2005). In order to determine if EnvP(b) and EnvV
could induce BeWo cell fusion, the previously described fusion assay
was ﬁrst tested in 293 T and COS-7 cells (Blaise et al., 2005)
(Figs. 4A and B). Both cell lines were transfected with plasmids
encoding different HERV-derived envelope proteins: EnvP(b), EnvV,
Syncytin-1 and Syncytin-2, with phCMV1 used as a negative control.
Forty eight hours post-transfection, cells were examined for fusion
events under a confocal microscope after staining of the cytoplasm
and the nucleus. As previously described (Blaise et al., 2003),
Syncytin-1- and Syncytin-2-expressing vectors led to fusion of 293 T
and COS-7 cells, while EnvV expression had no similar capacity
(Figs. 4A and B). As opposed to the previous report by Blaise et al.
(2005), in our hands, moderate but signiﬁcant fusion was noted in
EnvP(b)-expressing 293 T cells in addition to expected fusion events
observed in COS-7 cells. Importantly, no fusion was observed in
EnvP(b)- or EnvV-expressing BeWo cells (Fig. 4C). As expected, fu-
sion was noted in Syncytin-1- and Syncytin-2-expressing BeWo
cells. In this experiment, two different EnvP(b) and EnvV expression
vectors were tested and no impact on cell fusion was observed in
BeWo cells (data not shown).
These data thereby suggested that only Syncytin-1 and Syncytin-2
induce fusion of BeWo cells while overexpression of either EnvP(b)
or EnvV in the context of this latter cell line did not induce fusion.
Repression of EnvP(b) expression does not alter forskolin-induced BeWo
cell fusion
As EnvP(b) has retained its fusogenic properties as determined
in different cell lines (Blaise et al., 2005) (see Fig. 4A), the above re-
sult was unexpected. However, these results could be explained by
the fact that the speciﬁc receptor for EnvP(b) is only expressed inluc 
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ts carrying the complete 5′LTR ampliﬁed from proviral DNA containing HERV EnvP(b)
in BeWo cells. At 24 h post-transfection, cells were stimulated with 50 μM forskolin in
Results are shown as fold induction and compared to fold induction measured in
phCMV 
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Fig. 4. Fusogenicity of the HERV env proteins. Expression vectors pCMV-Syncytin-1, pCMV-Syncytin-2, pCMV-envP(b) and pCMV-envV (vs. the empty vector phCMV1) were transfected
in 293 T (A), COS-7 (B) or BeWo cells (C) and cell fusion was assessed after 48 h. BeWo cells were ﬁxed in methanol and stained using propidium iodide and a monoclonal anti-
desmoplakin antibody, while 293 T and COS-7 cells were stained with CellMask™Plasma Membrane and SYTO® 13 live-cell nucleic acid ﬂuorescent dyes. Cell lines were visualized
by confocal microscopy at a 400× magniﬁcation (scale bars, 100 μm). Results are representative of four independent experiments. Syncytia are indicated by white arrows.
5A. Vargas et al. / Virology 425 (2012) 1–10stimulated BeWo cell. In order to clearly rule out this possibility,
we were thus interested in conﬁrming the above results using a
RNA interference approach.
We thus compared the impact of previously tested Syncytin-2-
speciﬁc siRNAs (Vargas et al., 2009) to two different sets of siRNAs
designed against EnvP(b). Control siRNAs representing mutated
version of Syncytin-2-speciﬁc siRNA were used as negative controls
in these analyses. BeWo cells were ﬁrst stimulated by forskolin and
then transfected with the various siRNAs. Expression of both HERV
env genes was analyzed by RT-PCR and compared to mRNA levels of
β-actin. Results showed the expected repression of EnvP(b) and
Syncytin-2 when BeWo cells were transfected with speciﬁc siRNAs,
while BeWo cells transfected with control siRNAs demonstrated a
normal level of expression of both HERV env genes in unstimulated
and stimulated conditions (Fig. 5A).
We next evaluated the impact of our siRNAs on cell fusion in acti-
vated BeWo cells (Fig. 5B). As we have previously reported, siRNAs
speciﬁc to Syncytin-2 had a drastic inhibitory effect on cell fusion.
When BeWo cells were transfected with the EnvP(b)-speciﬁc siRNAs,
no effect on the extent of cell fusion was noted, regardless of the test-
ed siRNA. These results were better illustrated by comparison of the
cell fusion index measured in different BeWo cell population trans-
fected with different siRNAs (Fig. 5C). In all of these experiments,
our analyses indicated that control siRNAs had no impact on cell
fusion.Our data thus demonstrated that, in the context of stimulated
BeWo cells, EnvP(b) is not required for cell fusion, unlike both
Syncytin-1 and Syncytin-2 as we have previously reported (Vargas
et al., 2009).
Discussion
During placentation, trophoblasts differentiate and undergo
fusion, a complex process, which implicates several morphological
changes. We and others had previously shown that Syncytin-1 and
Syncytin-2 play a crucial role in this cellular fusion process, more pre-
cisely during syncytialization of villous cytotrophoblasts (Blaise et al.,
2003; Blond et al., 2000; Frendo et al., 2003; Mi et al., 2000; Rote et al.,
2004). However, other cellular factors including HERV env proteins
such as EnvP(b) and EnvV were proposed to be candidates involved
in this process (Blaise et al., 2005). In this study, our aim was to char-
acterize EnvP(b) and EnvV transcripts, to determine their expression
pattern and to assess their potential role in trophoblast fusion. Based
on our results, we clearly demonstrate that these two HERV env
genes, although induced in stimulated BeWo cells, do not play a sig-
niﬁcant role in trophoblast fusion.
We ﬁrst mapped the 5′ and 3′ ends of the two transcripts. We
showed that both EnvP(b) and EnvV are transcribed as typical spliced
envmRNA starting in the 5′ LTR region and terminating in the 3′ LTR.
Transcription of both HERV env genes initiated from a single
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microscopy at a magniﬁcation of 400×. Scale bars represent 100 μm. (C) Cellular fusion index was determined as follow: three ﬁelds were counted per well and an average was
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of a putative CAAT box for EnvP(b) and a TATA-like box for both
EnvP(b) and EnvV. Interestingly, for EnvV, an additional spliced
transcript was characterized, which led to the splicing of a third
untranslated exon into the 3′ untranslated region of exon 2. Such a
multispliced pattern for endogenous retroviral env transcripts has
also been reported for mouse ERV syncytin-A and syncytin-B genes
(Dupressoir et al., 2005). Several interesting features characterized
this alternatively spliced EnvV transcript. First, although the alterna-
tive spliced 3′ end was detected in several sequenced clones, a non
concensus splice donor site was present next to the spliced junction
in the proviral DNA. Secondly, two sites of poly A addition were iden-
tiﬁed and depended on ﬁve potential superimposed poly A signal.
For the moment, we cannot determine to which extent this new splic-
ing event and this new poly A site are contributing to the expression
of EnvV and further experiments will thereby be needed.
We then compared HERV env gene mRNA expression in different
cell lines and in isolated primary cytotrophoblasts at different time
points after isolation. In non-fusing JEG-3 and Jar cells, only EnvP(b)
mRNA was detected, although no variation in its expression could
be observed upon stimulation. In the fusogenic BeWo cell line, we ob-
served an important increase in the level of EnvP(b) and EnvVmRNAsupon stimulation with forskolin. In agreement with these results, pro-
moter studies for both genes highlighted a poor activity in non-
stimulated BeWo cells with a signiﬁcant increment upon stimulation.
In primary isolated cytotrophoblasts, expression did increase in cul-
ture condition but dropped drastically before peak fusion. Although
this pattern of expression is reminiscent of Syncytin-2, differences
are nonetheless noticeable in that Syncytin-2 demonstrated a more
sustained expression level up to day 4 of culture (Vargas et al., 2009).
In order to fully assess the possible involvement of the fusogenic
EnvP(b) protein (and perhaps the EnvV protein) in trophoblast fu-
sion, we ﬁrst overexpressed HERV env genes in BeWo cells. No induc-
tion of fusion events was observed in EnvP(b)- or EnvV-expressing
BeWo cells, in contrast to Syncytin-2-expressing cells. To conﬁrm
our observations, siRNA transfection experiments were conducted
in stimulated BeWo cells and, unlike Syncytin-2-speciﬁc siRNAs,
which culminated into a drastic reduction in fusion (as we had initial-
ly reported Vargas et al., 2009), repression of EnvP(b) expression did
not block cell fusion.
Based on data obtained in the present study, trophoblast fusion
does not require expression of EnvP(b) or EnvV. Although we have
not directly tested the implication of these proteins in primary tro-
phoblasts, pattern of expression of EnvP(b) and EnvV genes in
7A. Vargas et al. / Virology 425 (2012) 1–10comparison to peak cell fusion might argue that these HERV proteins
are not involved in fusion of these primary cells. In BeWo cells, we
assume that the receptor for EnvP(b) is absent in unstimulated and
stimulated cells thereby abrogating the capacity of this HERV Env
protein to mediate fusion. In parallel, it is interesting to note that
Syncytin-2 did induce fusion in BeWo cells and thereby suggest that
low but sufﬁcient amount of the MFSD2 receptor is present at the
surface of these cells for fusion to occur. Alternatively, it could be sug-
gested that, in overexpression condition, Syncytin-2 uses a second
unknown receptor. However, it also remains possible that none of
the tested models herein are optimal for the study of the implication
of EnvP(b) in fusion events. Indeed, there are different steps in pla-
centation and, during this complex process, numerous fusion events
occur. The BeWo choriocarcinoma cell line and primary cytotropho-
blasts are reliable models for the study of fusion but might not
account for all types of fusion events occurring in the placenta.
In a recent report, a putative immunosuppressive domain present
in both envelope proteins has been shown to have maintained a sup-
pressive effect on the immune response (Mangeney et al., 2007). It is
thereby possible that EnvP(b) and EnvV could potentially be implicat-
ed in the state of immunotolerance prevailing during pregnancy. In
fact, as previous studies has suggested that pre-eclampsia could
be associated with a defect in immunotolerance (Kaaja and Greer,
2005), we have tested placenta tissue from pre-eclamptic patients
and our preliminary results indicate that EnvV mRNA expression is
reduced in PE placentas (2 fold less) (Supplementary data 1).
Overall, our results thereby indicate that trophoblast fusion likely
requires a limited number of HERV Env proteins and that Syncytin-1
and Syncytin-2 might be the only two HERV Env proteins necessary
to mediate this biological process. This is expected and allows a
more delicate control of the fusion process. Further experiments
will however be needed to conﬁrm that EnvP(b) is not playing a
role in particular types of fusion occurring in the placenta, which
might not have been well represented in our model. Due to its
fusogenic-potential in the context of other cell lines such as HeLa,
COS-7 and TE671 and its ubiquitary expression pattern, EnvP(b)
could be implicated in other fusion processes implicating myoblasts
(Taylor, 2000) and preosteoclasts (Ejiri, 1983). We are currently
addressing these different possibilities.
Conclusions
EnvP(b) is a fusogenic protein, which was initially suggested to
have a potential role in trophoblast fusion. Our results have indicated
that neither EnvP(b) nor the non-fusogenic EnvV proteins are re-
quired in the fusion process of trophoblast. Other role for these pro-
teins need to be further addressed such as a possible implication in
immunotolerance during pregnancy or for EnvP(b), a role in other
types of fusion processes.
Materials and methods
Cell culture
Human cell lines BeWo, JEG-3 and Jar were obtained from the
American Type Culture Collection (ATCC, Manassas, VA) and main-
tained in Ham's F-12, MEM and RPMI medium, respectively (Wisent,
Montreal, Canada) supplemented with 10% fetal bovine serum (FBS)
(PAA Laboratories Inc., Toronto, Canada) and 2 mM L-glutamine (Invi-
trogen Canada Inc., Burlington, Canada) at 37 °C in a 5% CO2 atmo-
sphere. 293 T and COS-7 cells were maintained in DMEM medium
supplemented with 10% FBS and 2 mM L-glutamine. Human placental
tissues were provided by pregnant women after informed consents
and approval was issued by the Ethic Committee from the Centre de
recherche du Centre Hospitalier de l'Université de Montréal. Placental
villi were cut and thoroughly washed to remove blood. Thereafter,they were incubated four times in a digestion medium composed of
Hanks' balanced salt solution containing trypsin (from 9.6×105 to
1.8×106 U/digestion) and DNase I (Roche Diagnostics, Indianapolis
IN) (from 19 to 37.5 mg/digestion) for 30 min at 37 °C in a water
bath with continuous shaking. The dispersed cells were layered on
top of a discontinuous 5–70% Percoll gradient and centrifuged for
25 min at 507 g. The intermediate layers (density between 1.048
and 1.062) containing cytotrophoblast cells were removed and
washed extensively, and cell viability was determined by trypan
blue exclusion. Following trophoblast isolation, cells were seeded at
a density of approximately 1.5×106 cells per well in a 24-well plate.
After 16 h, cells were washed with phosphate-buffered saline (PBS)
1× and fresh medium was subsequently added. Culture medium con-
sisting of DMEM-HG (Dulbecco's modiﬁed Eagle's medium with high
glucose), 2 mM L-glutamine, 10% FBS, and PSN (penicillin/streptomy-
cin/neomycin) (1×) (Invitrogen), was refreshed daily and trophoblasts
were maintained for a maximum of four days in culture. The purity
of each preparation of cytotrophoblasts was evaluated by ﬂow cytome-
try using FITC (ﬂuorescein isothiocyanate)-conjugated monoclonal
antibody against cytokeratin-7 (Millipore, Mississauga, Canada), a
speciﬁc trophoblast marker. Only preparations with a minimum of
96% of cytotrophoblasts were further used for experiments. All experi-
ments with isolated primary trophoblasts were conducted in triplicate
under normoxia conditions and repeated three times, in each case
with a different placenta donor.
Plasmids
DNA fragments containing the expected EnvP(b) and EnvV pro-
moter regions were PCR-ampliﬁed from human primary cytotro-
phoblast genomic DNA with EnvP(b)-speciﬁc forward 5′-
ATCTCGAGCTATCTCCACTGTGCC-3′ and reverse 5′-CTGGGAGATGAC-
CAGAGACC-3′ primers and EnvV-speciﬁc forward 5′-AGCCTGGGCGA-
CAGAGTGAGA-3′ and reverse 5′-TGGATAACCAGGCGAGGTAACC-3′
primers. The ampliﬁed fragments were then cloned into pGL3-Basic
(Promega, Madison, WI) at the SacI/SmaI site for the EnvP(b) promot-
er and into SmaI for the EnvV promoter. Resulting plasmids were
termed EnvP(b)LTR-luc and EnvVLTR-luc. The coding regions of
EnvP(b) and EnvV were PCR-ampliﬁed from cytotrophoblast
genomic DNA with the primers 5′-GAGGGACCATATCTAGTGCTCCT-3′
(forward) and 5′-GGAGGGCTGATAGATGAATGGGTAT-3′ (reverse)
for EnvP(b) and 5′-CACTAAACACTCCATCGAACCA-3′ (forward) and
5′-AAAAGCAAAAGGCTGTTCTAGGATGG-3′ (reverse) for EnvV. Ampli-
ﬁed products were subsequently cloned in the pDrive vector and con-
ﬁrmed by sequencing. Both cDNAs were then excised by XhoI/KpnI
and cloned into the phCMV1 vector (Genlantis, San Diego CA) using
the same restriction enzymes (phCMV1-EnvP(b) and phCMV1-
EnvV). Expression vectors phCMV-Syncytin-1 and phCMV1-
Syncytin-2 have been described before (Vargas et al., 2009). The
pRc-Actin-lacZ vector contains the β-galactosidase gene under the
control of the β-actin promoter.
RT-PCR and RACE analysis
Total RNA was isolated from cell lines or human primary tropho-
blasts using the RNeasy Kit following manufacturer's instructions
(Qiagen, Mississauga, Canada). RNA (0.5 μg) was then incubated in
the presence of oligo(dT) (25 ng/μl), 10 mM DTT, 100 μM dNTP
(deoxynucleotide triphosphate), SuperScript II reverse transcriptase
(10 U) (Invitrogen Canada Inc), and SUPERase-In (20 U) at 42 °C for
50 min. Aliquots from the RT reactions were then PCR-ampliﬁed in
the presence of 2 U Vent DNA polymerase (New England Biolabs,
Pickering, Canada), 1× ThermoPol buffer, 100 μM dNTP and 15 μM
of each primer. For standard RT-PCR analyses, primers used for
EnvP(b) cDNA ampliﬁcation were 5′-CTCTCCCTTGCCTCTGCTTT-3′
(forward) and 5′-CGTTGCGCTAAGAGACCTT-3′ (reverse), while, for
Table 1
Sequence of tested siRNAs.
Target gene Name siRNA sequence
Syncytin-2 si-Sync-2 5′-rCrCUrArCrCrGrCrCrAUrCrCUrGrAUUU d(TT)-3′
None CTL-si 5′-rCrCUrCrCrGrCrCrCUrArArGUrCrAUUU d(TT)-3′
EnvP(b) si-envP(b)#1 5′-rGrGrAUrArArAUUrArCrAUrCUrAUUrA d(TT)-3′
EnvP(b) si-envP(b)#2 5′-rArGrGrArAUrArGrCUrGrArArCrArAUUrA d(TT)-3′
The sequence of a single strand is presented. Underlined nucleotides represent mutations
in the control siRNA diverging from the corresponding Syncytin-2 siRNA.
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TATCCA-3′ (forward) and5′-AAGGAATTTCTCTGTCATAGCT-3′ (reverse).
For ampliﬁcation of β-actin cDNA, primers 5′-CGTGACATTAAGGA-
GAAGCTG-3′ (forward) and 5′-CTCAGGAGGAGCAATGATCTT-3′ (re-
verse) were used. PCR conditions were as follow: a ﬁrst step of
denaturation at 94 °C for 3 min followed by 35 cycles of denaturation
(94 °C for 30 s), annealing (58 °C for 30 s), and extension (72 °C for
30 s). Both 5′ and 3′ ends of EnvP(b) and EnvV RNAs were determined
using total RNA isolated from primary cytotrophoblasts with the First-
Choice RLM-RACE Kit (Ambion) according to manufacturer's instruc-
tions. Brieﬂy, cDNAs were synthesized in the presence of random
decamers and 5′ ends were ampliﬁed by two PCR rounds using outer
and inner RACE primers and EnvP(b)/EnvV-speciﬁc reverse outer
primers (5′-CAAGGGCTAGAGATTGGGACC-3′ and 5′-GGGTGAGTCT-
GATCTAGTTACGT-3′) followed by reverse inner primers (5′-CAAGAAC-
CAGAGGACTTCCACAC-3′ and 5′-TCAGGCGCTGAATTCTGTTGTTCCT-3′),
all being positioned at the 5′ end of coding regions. For the 3′
RACE protocol, cDNA synthesis was performed in the presence of
the supplied 3′ RACE adapter. PCR ampliﬁcation was achieved through
the use of outer and inner 3′ RACE primers and two EnvP(b)/EnvV-
speciﬁc forward primers derived from the sequence downstream
of the stop codon (5′-GCATCGAAGGTAATGGTCTGGGG-3′ and 5′-
CTCGAGGGGCGGTGCTTTCTTGACTCGGG-3′ for EnvP(b), and 5′-GATAT-
CAGCTATCTGTCATTGGAG-3′ and 5′-ATCTCGAGTCTCCATCTCTTGAG-
GAGGGAA-3′ for EnvV). Ampliﬁed products were subsequently
cloned into pBlueScript KS+ and sequenced.
Real-time RT-PCR
RNA was isolated from unstimulated or forskolin-stimulated
BeWo cells and from human primary trophoblasts using the RNeasy
kit. Real-time RT-PCR reactions were then performed in the presence
of each speciﬁc primer. Brieﬂy, PCR reactions were initiated in a ﬁnal
volume of 10 μl containing 1 μl of cDNA, 0.5 μM of each primer, and
1× reactionmix, including the TaqDNA polymerase, the reaction buff-
er, and SYBR green (SYBR® Premix Ex Taq™: Perfect Real Time). All
primer sequences were generated using the Light Cycler Probe Design
Software 2.0 (Roche Diagnostics, Indianapolis, IN) and veriﬁed for
speciﬁcity using GenBank Blast analysis. The EnvP(b) primers were
5′-CAAGGGCTAGAGATTGGGACC-3′ (reverse) and 5′-GGGTGAGTCT-
GATCTAGTTACGT-3′ (forward). For EnvV, the reverse and forward
primers designed for these experiments were 5′-CAAGAACCAGAG-
GACTTCCACAC′ and 5′-CAGGCGCTGAATTCTGTTGTTCCTT-3′, respec-
tively. In all PCR reactions, negative controls consisting of an RT-like
reaction step with no added reverse transcriptase in addition to a
blank sample were carried out and showed no PCR ampliﬁcation
(data not shown). Thermal cycling for quantiﬁcation of both
transcripts was initiated with a denaturation step of 95 °C for 10 s,
followed by 50 cycles (denaturation at 94 °C for 3 s, 57 °C for anneal-
ing during 15 s, and elongation at 72 °C for 12 s). Ampliﬁcation of the
human HPRT-1 (hypoxanthine phosphoribosyl transferase 1) cDNA
with sense and antisense primers (5′-AAGCTTGCGACCTTGACC-3′
and 5′-GACCAGTCAACAGGGGACATAA-3′, respectively) was used as
a reference for normalization. To verify the ampliﬁcation of each
single product with its suitable melting temperature and to provide
an accurate quantiﬁcation with the Rel Quant Software, dissociation
curves were run for all reactions and ampliﬁed products were visual-
ized by electrophoresis on a 2% agarose gel.
Luciferase assay
BeWo cells (2×105) were co-transfected with envP(b)LTR-luc,
envVLTR-luc or pGL3-Basic (0.1 μg) and pRc-Actin-LacZ (0.1 μg)
using the FuGENE 6 transfection reagent according to manufacturer's
instructions (Roche Diagnostics). Twenty-four hours after transfec-
tion, cells were washed once with fresh medium and treated with50 μM forskolin for 8 h. Transfected cells were lysed in 25 mM Tris
phosphate (pH 7.8), 2 mM DTT, 1% Triton X-100, and 10% glycerol,
and luciferase activity was measured with the MLX Microplate Lumin-
ometer apparatus (Dynex Technologies) following a single injection of
a luciferase buffer [20 mM tricine, 1.07 mM (MgCO3)4·Mg(OH)2·5H2O,
2.67 mM MgSO4, 0.1 mM EDTA (ethylenediaminetetraacetic acid),
220 μM coenzyme A, 4.7 μM D-luciferin potassium salt, 530 μM ATP,
33.3 mM DTT]. The β-galactosidase activity was measured using the
Galacto-Light™ kit (Applied Biosystems, Bedford, MA) according to
manufacturer's instructions. Luciferase activity was calculated in terms
of relative light units (RLU) and was adjusted in their values based
on the values ofmeasuredβ-galactosidase activities for each transfected
samples. Luciferase activities thus represent mean values±SD of three
transfected samples normalized for β-galactosidase activity. Fold in-
ductions were calculated by dividing the values of activated samples
by values of non-stimulated samples. Statistical analyses were per-
formed using an unpaired Student's t test with StatGraphics. A value
of pb0.05 was considered signiﬁcant.
siRNA transfection
All siRNAs were synthesized by Qiagen (Mississauga, Canada). Se-
quences of sense and nonsense siRNAwere blasted using the Ensembl
blast algorithm and no signiﬁcant homologies with cDNA or genomic
sequences (other than the intended targeted genes) were detected.
BeWo cells (1.5×105 cells) were ﬁrst plated in 24-well plates, stimu-
lated with 50 μM forskolin and transfected after 16 h of stimulation
using Hiperfect (Qiagen) in the presence of 37.5 ng of siRNA duplexes
corresponding to two different regions of Syncytin-2 or EnvP(b) tran-
scripts (Table 1). After 36 h of transfection, the efﬁciency/speciﬁcity
of each siRNA was analyzed by RT-PCR analyses, while the impact
on cell fusion was addressed by cell fusion assay.
Cell fusion assay
BeWo cells (1×105) were plated in 24 well plates and, after 16 h,
were transfected with phCMV1-Syncytin-1, phCMV-Syncytin-2,
phCMV-EnvP(b) and phCMV-EnvV (0.2 μg) using the FuGENE 6 re-
agent according to manufacturer's instructions or with siRNAs using
Hiperfect reagent (Qiagen). BeWo cells transfected with siRNAs
(1×105 cells) were plated in 24-wells plates and stimulated or not
with forskolin (50 μM). In both sets of transfection, BeWo cells were
then ﬁxed in cold methanol for 30 min and incubated in PBS contain-
ing 2% FBS (v/v) for 30 min to eliminate non-speciﬁc binding. Cells
were rinsed with PBS and incubated in the presence of mouse mono-
clonal anti-desmoplakin antibody (Sigma-Aldrich, Oakville, Canada
cat. no. D-1286; 1/700) in PBS containing 0.2% bovine serum albu-
min for 1½ h at room temperature, washed three times with PBS,
and incubated with the Alexa Fluor 488-conjugated goat anti-
mouse IgG (Invitrogen; 1/1000) for 1 h at room temperature. For nu-
clear staining, cells were incubated with propidium iodide (Sigma-
Aldrich) (PI; 50 μg/ml) for an additional 30 min at room temperature
and washed three times with PBS. Fusion assay for 293 T and
COS-7 cells were conducted as follow. Cells (1×105) were trans-
fected in 24-well plates with 0.8 μg of phCMV-env expression vec-
tors using the Lipofectamine™ Reagent (Invitrogen) according to
9A. Vargas et al. / Virology 425 (2012) 1–10manufacturer's instructions. After 48 h, cells were incubated with
the CellMask™Plasma Membrane dye (5 μg/ml) diluted in supple-
mented medium at 37 °C for 5 min, rinsed three times with PBS and
subsequently incubated with the SYTO® 13 live-cell nucleic acid ﬂuo-
rescent dye (5 μM) diluted in supplemented medium (Invitrogen) for
5 min. BeWo, COS-7 and 293 T cell preparations were visualized
under a confocal laser-scanning microscope (Bio-Rad MRC1024, Her-
cules, CA) at a ﬁnal magniﬁcation of 400×. A syncytium was deﬁned
as an agglomeration of two or more nuclei in the same cytoplasm
without intervening surface membrane staining. Cellular fusion
index was determined as follows: three ﬁelds were counted per
well and an average was calculated and expressed as the percentage
number of nuclei in syncytia. In general, a total of 200 nuclei were
counted per ﬁeld and, thus, nearly 600 nuclei were counted in each
well. Three replicate wells were examined per experimental condi-
tion from which a ﬁnal cellular fusion index (mean±SEM) is pre-
sented and represents the ﬁnal average of the three percentage
values. Statistical analyses were performed using an unpaired
Student's t test with StatGraphics. A value of p≤0.05 was considered
to be signiﬁcant. Results are representative of three independent
experiments.
Supplementary materials related to this article can be found
online at doi:10.1016/j.virol.2011.12.015.
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